Hannover Rück SE buy Sargnagel
Start price
21.06.12
/
50%
€45.93
Target price
29.08.12
€52.00
Performance (%)
5.27%
End price
29.08.12
€48.35
Summary
This prediction ended on 29.08.12 with a price of €48.35. With a performance of 5.27%, the BUY prediction by Sargnagel for Hannover Rück SE closed with a slight gain. Sargnagel has 50% into this predictionHannover Rück is a German reinsurance company that operates globally, offering individualized solutions to clients such as primary insurers, industrial firms, and brokers. The company's portfolio includes life and health, casualty and property reinsurance, and specialty lines. Hannover Rück is listed on multiple stock exchanges, including the Frankfurt Stock Exchange, and trades under the symbol HVRRF. The company's focus on risk management, innovation, and collaboration has helped it maintain a strong presence in the global reinsurance market.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hannover Rück SE | 0.707% | 0.707% | 14.214% | 57.538% |
| iShares Core DAX® | -0.205% | 2.528% | 16.157% | 18.725% |
| iShares Nasdaq 100 | 1.613% | 4.733% | 30.626% | 56.133% |
| iShares Nikkei 225® | -0.740% | 0.396% | 9.039% | 5.948% |
| iShares S&P 500 | 0.267% | 2.720% | 26.333% | 47.720% |
Comments by Sargnagel for this prediction
In the thread Hannover Rück SE diskutieren
einer der größten Rückversicherer
Die Hannover Rückversicherung ist für mich ein klarer Kauf. Eine günstige Bewertung und eine hohe Dividenrendite sichern die Aktie nach unten ab.